Concepedia

Publication | Open Access

CS1, a Potential New Therapeutic Antibody Target for the Treatment of Multiple Myeloma

555

Citations

43

References

2008

Year

Abstract

These results suggest that HuLuc63 eliminates myeloma cells, at least in part, via NK-mediated ADCC and shows the therapeutic potential of targeting CS1 with HuLuc63 for the treatment of multiple myeloma.

References

YearCitations

Page 1